GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Cash from Discontinued Operating Activities

VRCDF (Verici Dx) Cash from Discontinued Operating Activities : $0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Verici Dx's Cash from Discontinued Operating Activities for the six months ended in Jun. 2024 was $0.00 Mil. It means Verici Dx received $0.00 Mil from discontinued investing activities. Verici Dx's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 was $0.00 Mil.


Verici Dx Cash from Discontinued Operating Activities Historical Data

The historical data trend for Verici Dx's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Cash from Discontinued Operating Activities Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash from Discontinued Operating Activities
- - - -

Verici Dx Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash from Discontinued Operating Activities Get a 7-Day Free Trial - - - - -

Verici Dx Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Verici Dx Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Verici Dx's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.


Verici Dx Business Description

Industry
Traded in Other Exchanges
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies that will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, which of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx Headlines

No Headlines